Treatment Innovations

The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

• Treatment Innovations

The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

Lina Hope October 2, 2026

The pharmaceutical landscape is undergoing a profound transformation. The meteoric rise of GLP-1 receptor agonists—initially hailed for...

Read More Read more about The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

• Treatment Innovations

Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

Muslim October 2, 2026

The pharmaceutical landscape is currently undergoing a period of intense structural and clinical transformation. As of September...

Read More Read more about Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

• Treatment Innovations

Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

Nana Muazin October 2, 2026

For decades, the pharmaceutical industry has operated under a veil of insularity when it comes to the...

Read More Read more about Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

• Treatment Innovations

The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

Suro Senen October 2, 2026

The landscape of metabolic healthcare is undergoing a tectonic shift. For decades, the management of conditions such...

Read More Read more about The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

• Treatment Innovations

The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

Asro October 2, 2026

The U.S. Department of Health and Human Services (HHS) has officially signaled the beginning of a radical...

Read More Read more about The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting

• Treatment Innovations

The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting

Asro October 1, 2026

The global landscape of metabolic medicine is currently defined by a high-stakes race for dominance in the...

Read More Read more about The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting

Pharma’s New Frontier: How Sweeping Section 232 Tariffs are Reshaping the Global Drug Supply Chain

• Treatment Innovations

Pharma’s New Frontier: How Sweeping Section 232 Tariffs are Reshaping the Global Drug Supply Chain

Laily UPN October 1, 2026

The landscape of American pharmaceutical manufacturing is undergoing its most significant structural upheaval in decades. As of...

Read More Read more about Pharma’s New Frontier: How Sweeping Section 232 Tariffs are Reshaping the Global Drug Supply Chain

Strategic Pivot: Inogen Divests US Rental Business to Rotech Healthcare in $25M Realignment

• Treatment Innovations

Strategic Pivot: Inogen Divests US Rental Business to Rotech Healthcare in $25M Realignment

Laily UPN October 1, 2026

In a definitive move to reshape its operational footprint and sharpen its focus on core product innovation,...

Read More Read more about Strategic Pivot: Inogen Divests US Rental Business to Rotech Healthcare in $25M Realignment

Safety Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Amid Liver Toxicity Risks

• Treatment Innovations

Safety Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Amid Liver Toxicity Risks

Reynand Wu October 1, 2026

Published: September 30, 2026 By: Jonathan Gardner The pursuit of new therapies for complex respiratory and fibrotic...

Read More Read more about Safety Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Amid Liver Toxicity Risks

Beyond the "Spaghetti": How Talus Bio is Disrupting Drug Discovery by Skipping Protein Folding

• Treatment Innovations

Beyond the "Spaghetti": How Talus Bio is Disrupting Drug Discovery by Skipping Protein Folding

Laily UPN October 1, 2026

The field of computational biology has been defined for the last several years by the singular, massive...

Read More Read more about Beyond the "Spaghetti": How Talus Bio is Disrupting Drug Discovery by Skipping Protein Folding